The increased replicative capacity of a late-stage simian immunodeficiency virus mne variant is evident in macrophage- or dendritic cell–T-cell cocultures  by Kimata, Jason T. et al.
www.elsevier.com/locate/yviroVirology 327 (20The increased replicative capacity of a late-stage simian
immunodeficiency virus mne variant is evident in macrophage-
or dendritic cell–T-cell cocultures
Jason T. Kimataa,*, Joelle M. Wilsonb, Parul G. Patelb
aDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, United States
bDepartment of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, TX 78227, United States
Received 26 May 2004; returned to author for revision 10 June 2004; accepted 13 July 2004Abstract
Human and simian immunodeficiency virus (HIV and SIV) may co-opt antigen capture and presentation functions of antigen presenting
cells (APCs) to facilitate infection of CD4+T-cells. To address whether the replicative capacity of SIV in the host may be associated with the
extent of viral replication in response to APC–T-cell interactions, we compared the replicative phenotypes of cloned early and late-stage
SIVmne variants of known pathogenicity. Here, we show that the highly pathogenic late variant SIVmne027 replicates more efficiently in
both macrophage- and dendritic cell (DC)-T-cell cocultures than the minimally pathogenic early virus SIVmneCl8. Contact between either
macrophages or DC and T-cells increases replication of SIVmne027. Our analysis also demonstrates that mutations in pol and nef contribute
to the greater replicative capacity of SIVmne027 in DC– or macrophage–T-cell cocultures. Together, these data suggest that variant viruses
that evolve to replicate vigorously in response to APC–T-cell interactions may have increased replicative capacity in vivo.
D 2004 Elsevier Inc. All rights reserved.
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Cellular activation signals play a critical role in
regulating infection and replication of human immuno-
deficiency virus type 1 (HIV-1) and simian immuno-
deficiency virus (SIV) in CD4+T-cells. Induction of
signaling through the T-cell receptor/CD3 complex,
costimulatory molecules, or cytokine receptors has been
shown to release arrest in viral replication that occurs at
postentry steps before integration of the provirus (Kinosh-
ita et al., 1998; Korin and Zack, 1998; Polacino et al.,
1993, 1995; Scripture-Adams et al., 2002; Stevenson et al.,
1990; Unutmaz et al., 1999). Additionally, they may0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: jkimata@bcm.tmc.edu (J.T. Kimata).enhance transcription and virion production (Bukrinsky
et al., 1991; Chun et al., 1998; Scripture-Adams et al., 2002;
Smithgall et al., 1996). These activation signals can be
induced by contact between CD4+T-cells and antigen
presenting cells (APCs) such as dendritic cells (DCs) and
the local expression of cytokines within lymphoid tissue
(Steinman, 1991). Indeed, HIV-1 and SIV infection of
CD4+T-cells appears to occur most efficiently when virions
are presented in association with macrophages or DCs
(Bobardt et al., 2003; Cameron et al., 1992; Gummuluru
et al., 2002; McDonald et al., 2003; Pope et al., 1994, 1997;
Swingler et al., 2003; Weissman et al., 1996; Yu Kimata
et al., 2002). Thus, both viruses may hijack the antigen
capture and cellular activation functions of APCs to infect
CD4+T-cells. Furthermore, these data suggest that a virus’s
capacity to utilize and modulate cellular activation signals
for efficient replication in CD4+T-cells may define its
replicative fitness.04) 307–317
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tions for viral replication is underscored by the observation
that HIV-1 and SIV replication occurs predominantly in
lymphoid tissues at both early and late stages of infection
(Chakrabarti et al., 1994; Embretson et al., 1993; Pantaleo
et al., 1993). Furthermore, in situ studies of macaques
infected intravaginally with SIV show that the virus first
encounters dendritic cells (DCs) and macrophages in the
vaginal and cervical epithelium (Hu et al., 2000; Spira et al.,
1996). Within a few days, virus is localized to T-cell zones
of draining lymph nodes where robust viral replication
predominantly occurs in CD4+T-cells (Hu et al., 2000; Spira
et al., 1996). Interestingly, viruses present in lymphoid
tissue are a genetically distinguishable population (Camp-
bell and Hirsch, 1994). These studies suggest that variant
viruses that replicate efficiently in CD4+T-cells, following
presentation by APCs, may be selectively amplified and
propagated. However, despite the presumed importance of
lymphoid tissue in supporting HIV and SIV replication, it is
unclear whether adaptation to antigen-presenting cell–T-cell
interactions may be important for replication and persistence
of the infecting virus.
In previous studies, we cloned a SIVmne variant
(SIVmne027) from lymph node tissue of pig-tailed
macaque at a late stage of infection and demonstrated
that it was more pathogenic than the early virus
SIVmneCl8 (Kimata et al., 1998, 1999b). SIVmne027
caused a more rapid disease course and replicated to a
3000-fold higher level than SIVmneCl8 when transmitted
to naive macaques. The increased in vivo replication and
pathogenicity of SIVmne027 compared to SIVmneCl8
was associated with its greater replication rate in
peripheral blood mononuclear cells (PBMCs) in vitro,
and its enhanced viral infectivity and ability to down-
regulate CD4 from the surface of cells (Kimata et al.,
1998; Patel et al., 2002). Additionally, we found that
SIVmne027 could replicate in resting peripheral blood
mononuclear cells in a manner dependent on the presence
of monocyte/macrophages, suggesting that this virus may
replicate better in response to intercellular interactions
between CD4+T-cells and macrophages than SIVmneCl8
(Kimata et al., 1998).
In the present study, we further investigated whether the
late-stage LN-derived virus SIVmne027 replicates more
efficiently in response to contact between APCs and
CD4+T-cells compared to the early virus SIVmneCl8 or if
other factors such as cytokines may provide the primary
stimulus. Our data suggest that contact between macro-
phages or DCs and T-cells induces important signals that
drive high-level replication of SIV. They also provide
evidence that mutations selected in nef and pol of
SIVmne027 facilitate its replication. Together, the data
suggest that variant viruses may evolve to utilize APC–T-
cell interactions to replicate robustly and that these viruses
may have greater replicative capacity and pathogenic
potential in the host.Results
Replication of SIV in APC–T-cell cocultures
To investigate whether the late-stage LN-derived virus
SIVmne027 replicated to higher levels in DC–T-cell
cocultures compared to the early virus SIVmneCl8, we
pulsed DCs with equal amounts of virus and cocultured the
cells with autologous resting PBLs (Fig. 1A) or phytohe-
magglutinin (PHA)-lymphoblasts (Fig. 1B). An increase in
p27gag antigen occurred through day 3 in SIVmneCl8-
infected cocultures, peaking at 1000 pg/ml and subsequently
decreasing. By contrast, p27gag antigen concentration
peaked at a level 4- to 5-fold higher in SIVmne027-infected
DC-resting PBL coculture. The differences were more
dramatic in the coculture with PHA-lymphoblasts, where
SIVmne027 reached a 300-fold higher level than SIVm-
neCl8. In cells derived from a second pig-tailed macaque
donor, the differences in replication between SIVmneCl8
and SIVmne027 were even greater (Figs. 1C and D), where
SIVmne027 achieved a 1000-fold higher level than SIVm-
neCl8 in either coculture of DCs with resting PBL or PHA-
lymphoblasts. Interestingly, there was a limited difference in
the level of SIVmne027 replication between cocultures
using resting PBLs or PHA-lymphoblasts. Using cells
derived from a third pig-tailed macaque donor, we also
observed high-level replication of SIVmne027 regardless of
whether the DC-PBL cocultures used resting PBLs or PHA-
lymphoblasts (data not shown). Thus, while there appears to
be variation in the extent of replication of each virus that is
due to the donor cells and whether the PBLs are resting or
activated, SIVmne027 consistently replicates more effi-
ciently than SIVmneCl8.
Additionally, we compared the replication rates of
SIVmne027 and SIVmneCl8 in cocultures of monocyte-
derived macrophages and resting PBL. Similar to the results
of DC-resting-PBL coculture experiments, SIVmne027
replicated to a higher level than SIVmneCl8, and peak
p27gag antigen concentration was about 40-fold greater than
that achieved by SIVmneCl8 (Fig. 2). Similar results were
observed with cells from a second pig-tailed macaque donor
(data not shown).
As a control for replicative capacity of each virus,
CEMx174 cells and PHA-lymphoblasts were infected with
each virus (Fig. 3). SIVmne027 and SIVmneCl8 replicated
to similar levels in the human T-B hybrid cell line
CEMx174, reaching concentrations of about 2  106 pg
of p27gag per ml at day 16 postinfection (Fig. 3A). However,
SIVmne027 showed a delay in replication compared to
SIVmneCl8 in CEMx174 cells. By contrast, SIVmne027
demonstrated higher replication than SIVmneCl8 in PHA-
lymphoblasts with the peak p27 antigen level being
approximately 10-fold higher than the highest amount
SIVmneCl8 (Fig. 3B). Although the level of difference
between SIVmneCl8 and SIVmne027 varied between 3- and
50-fold with PBL derived from five additional pig-tailed
Fig. 1. Replication of SIVmne variants in DC-PBL cocultures. Cocultures of resting PBL (A and C) or PHA-lymphoblasts (B and D) and DC were infected
with either SIVmneCl8 or SIVmne027 and analyzed for virus replication as described in Materials and methods. All p27gag concentrations are the average
values calculated from duplicate cocultures. Cells and A and B were from a single pig-tailed macaque donor. Cells used in C and D were from a second pig-
tailed macaque.
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higher levels than SIVmneCl8 (data not shown). Thus,
while SIVmneCl8 is not defective, its replicative capacity is
relatively low in primary pig-tailed macaque PBLs.
Together, the data indicate that SIVmne027 has acquired a
greater capacity to replicate compared to the early parental
virus SIVmneCl8.Fig. 2. Infection of macrophage-resting PBL cocultures with SIVmne
variants. Macrophages were derived from monocytes, infected at an MOI of
0.001 with either SIVmneCl8 or SIVmne027, and cocultured with resting
PBL as described in Materials and methods. Virus replication was
monitored by SIV p27gag ELISA. SIV p27gag concentrations are the
averages of duplicate infections.Replication of SIV variants in resting T-cells, macrophages,
and DCs
To further characterize replication of SIVmne027 relative
to SIVmneCl8, we infected resting T-cells, monocyte-
derived macrophages, or monocyte-derived DCs (Fig. 4).
Over a 2-week period, the early virus SIVmneCl8 did not
replicate in resting T-cell cultures or dendritic cell cultures,
but replicated in monocyte-derived macrophages. Low
p27gag antigen production was observed in resting T-cell
and macrophages infected with the late LN-derived
SIVmne027 variant. Addition of IL-2, IL-4, IL-7, or IL-15
did not increase virus infection or production from resting T-
cells infected with either SIVmneCl8 or SIVmne027 (data
not shown). Neither SIVmneCl8 nor SIVmne027 replicated
in monocyte-derived DCs.
Because R5-tropic HIV-1 can infect monocyte-derived
DC differentiated with GM-CSF and IL4, and because both
SIVmne027 and SIVmneCl8 can use CCR5 for entry
(Granelli-Piperno et al., 1998; Kimata et al., 1999a), we
examined DCs incubated with SIVmne027 by quantitative
real-time taqman PCR for evidence of infection. Fewer than
10 copies of a late RT product (R-UTR) were detected per 1
105 DCs. This contrasts with infected macrophages where
approximately 220 copies of the target proviral DNA
sequence could be detected per 1  105 cells (data not
Fig. 3. Infection of CEMx174 cells and PHA-lymphoblasts with SIVmne
variants. (A) Replication of SIVmneCl8 and SIVmne027 in CEMx174
cells. (B) Replication of SIVmneCl8 and SIVmne027 in pig-tailed macaque
PHA-lymphoblasts. CEMx174 cells or PHA-lymphoblasts were infected at
a MOI 0.001 with either SIVmneCl8 or SIVmne027. SIV p27gag
concentrations are the averages of duplicate infections. The data are
representative of six independent infections.
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support high-level replication of SIVmne027. Moreover, pig-
tailed macaque DCs appear to be refractory to infection by
SIVmne. Thus, it may be that viral replication in T-cells isFig. 4. Infection of pig-tailed macaque resting T-cells, macrophages, and
DCs. Cells were infected at a MOI 0.01 with SIVmneCl8 (Cl8) or
SIVmne027 (027), washed twice with PBS, and cultured for a 3-week
period. Viral replication was monitored by assaying supernatants for SIV
p27gag antigen by ELISA. Peak antigen levels occurred about 12 days
postinfection. Resting T-cells, monocyte-derived macrophages (MDM), and
DCs were prepared as described in Materials and methods. SIV p27gag
concentrations are the averages determined from duplicate cultures.induced by interactions between T-cells and either macro-
phages or DCs.
APC–T-cell contact and SIVmne027 replication
To assess whether contact between APC and T-cells was
necessary for enhancement of SIVmne027 replication,
infections were set-up in which the DCs or macrophages
were cocultured with autologous PHA-lymphoblasts either
directly or with separation by a transwell membrane that
prevents contact between the PHA-lymphoblasts and the DCs
or macrophages but allows media, soluble cellular factors,
and cell-free virions to pass between the chambers. When
infected macrophages were cocultured with PHA-lympho-
blasts separated by a transwell membrane, limited viral
replicationwas observed that peaked around 1200 pg/ml at 13
days postinfection (Fig. 5A). Viral replication was 5-fold
higher when PHA-lymphoblasts were first infected withFig. 5. Cell contact-dependent enhancement of SIVmne027 replication. (A)
Replication of SIVmne027 in pig-tailed macrophage–T-lymphoblast
cocultures. Monocyte-derived macrophages were cocultured with autolo-
gous PHA-lymphoblasts in the presence or absence of a transwell barrier.
When a transwell membrane was used for separation of the cells, either the
macrophages (SIV-Mac/T-cells) or PHA-lymphoblasts (Mac/SIV-T-cells)
were infected with SIVmne027 before coculture. In the absence of a
transwell barrier, cocultures were directly infected with SIVmne027 (no
transwell). (B) Replication of SIVmne027 in pig-tailed macaque DC–T-cell
cocultures. Experiments were performed as in A, except using monocyte-
derived DC instead of macrophages. Viral replication was monitored by
assaying supernatants for SIV p27gag antigen by ELISA.
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phages separated by the transwell membrane. Replication of
SIVmne027 was even higher than that in PHA-lymphoblast-
infected cultures (7- to 8-fold) when the macrophages and
PHA-lymphoblasts were cocultured in the absence of the
transwell membrane. Similar observations were made when
DCs were cocultured with PHA-lymphoblasts instead of
macrophages, except that SIVmne027 did not replicate when
infected DCs were cocultured with PHA-blasts separated by
the transwell membrane (Fig. 5B). These data indicate that
viral replication in T-cells is enhanced by either macrophages
or DCs via a cell contact-dependent process.
Inhibition of viral replication in DC-T-cell cocultures by
anti-DC-SIGN MAb
To examine whether DC-SIGN was involved in the
enhancement of viral replication in DC-T-cell cocultures,
SIVmne027 replication was examined in cocultures contin-
uously treated with an anti-pig-tail macaque (pt) DC-SIGN
monoclonal antibody (8C1; Figs. 6A and B). Viral infection
was completely inhibited when DCs were treated with the
anti-ptDC-SIGN 8C1 MAb before incubation withFig. 6. Inhibition of SIVmne027 replication in DC–PHA-lymphoblast
cocultures by anti-ptDC-SIGN MAb. (A) Replication in the DC-lympho-
blast cocultures. (B) The percentage of p27gag relative to that in the mock-
treated cocultures at 17 days postinfection. DCs were either treated with the
anti-ptDC-SIGN MAb 8C1 before infection with SIVmne027 or 24 h after
infected DCs were cocultured with autologous PHA-lymphoblasts.
Fig. 7. Replication of SIVmne chimeric viruses. (A) Schematic diagram of
SIVmne027/SIVmneCl8 chimeric viruses. (B) Replication of SIVmne
chimeras in DC–PHA-lymphoblast cocultures. Monocyte-derived DCs
were infected with each of the indicated chimeric viruses and then
cocultured with autologous PHA-lymphoblasts as described in Materials
and methods. Virus infections were performed in duplicate, and virus
replication was monitored by SIV p27gag antigen ELISA. One of four
independent experiments is shown.SIVmne027 (Pre 8C1). Interestingly, even if the cocultures
were treated with the anti-ptDC-SIGN monoclonal antibody
8C1 24 h after cocultivation of virus-bearing DCs with
autologous PHA-lymphoblasts, production of SIVmne027
was reduced by 90% (Post 8C1). The control antibody did not
significantly diminish viral replication. Similar results have
been found in experiments using cells derived from a second
pig-tailed macaque. The data suggest that DC-SIGN plays an
important role in viral infection and replication, including the
initial capture and transfer of virus from DC to T-cells and
possibly events after it.
Determinants of the viral replication response to
APC–T-cell contact
Previously, we found that mutations in pol and nef
enhance the infectivity of SIVmne027 (Patel et al., 2002).
To examine whether these determinants confer greater
replication in DC–T-cell cocultures, we tested chimeric
viruses made by exchanging regions of SIVmne027 and
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the pol (8/027pol) or nef (8/027nef) had increased replication
compared to SIVmneCl8. However, the level of replication
was still below that of wild-type SIVmne027 (Fig. 7B). Gag
of SIVmne027 did not enhance replication (8/027gag). A
level of replication similar to wild-type SIVmne027 was only
conferred when both the pol and nef regions of SIVmne027
were inserted into SIVmneCl8 (8/027pol-nef), indicating that
both determinants have roles in increasing the replication rate
of SIVmne027.Discussion
Macrophages and DCs are among the earliest cells
encountered by SIV during infection of the host and are
believed to play a central role in the initiation of infection
and amplification of viral replication in CD4+T-cells
(Hirsch et al., 1998; Hu et al., 2000; Spira et al., 1996;
Zhang et al., 1999). In vitro and ex vivo lymphoid tissue
studies provide further evidence that interactions between
macrophages or DCs and T-cells drive efficient replication
of HIV-1 and SIV (Du et al., 1995; Kimata et al., 1998;
McDonald et al., 2003; Pope et al., 1994, 1997; Swingler
et al., 2003), indicating that these viruses may have co-
opted antigen capture and presentation mechanisms to
facilitate infection and replication in CD4+T-cells. Using
early and late-stage SIVmne clones of defined pathogenic-
ity (Kimata et al., 1999b), we showed that the highly
pathogenic late-stage SIVmne variant SIVmne027 repli-
cates to a higher level than the early minimally pathogenic
virus SIVmneCl8 in macrophage- or DC-T-cell cocultures,
even when resting T-cells are targets for infection. While
earlier studies established that both HIV and SIV may use
APC–T-cell interactions for replication, the data presented
here suggest that SIV may evolve in the host to exploit
antigen-presenting cell–T-cell interactions for viral repli-
cation. Furthermore, they support a hypothesis that virus
presentation by antigen-presenting cell to T-cells plays a
role in driving viral replication in the host.
We found that SIVmne027 and SIVmneCl8 display a
similar tropism for primary macaque cells. The major
difference is in the level of replication in activated T-cells,
where the late variant SIVmne027 replicates to a higher level
than the early virus SIVmneCl8. This observation is
consistent with our previous data and correlates with the
greater infectivity of SIVmne027 relative to SIVmneCl8
(Patel et al., 2002). By contrast, both viruses replicate to low
levels in cultures of pig-tailed macaque monocyte-derived
macrophages and do not replicate in monocyte-derived DCs
or resting T-cells, and there was no correlation between viral
infectivity and replication in these cells. Although we found
that pig-tailed macaque monocyte-derived DCs could be
infected by the SIVmne027 variant, quantitative real-time
PCR demonstrated that these cells are largely refractory to
infection. Similar results have been observed with rhesusmacaque monocyte-derived DC when infected with SIVmac
(Wu et al., 2002a). However, the data contrast with in situ
studies that show DC-SIGN+DCs in the lamina propria of
macaques are targets for infection (Choi et al., 2003). One
possible explanation for these differences is that monocytes
from macaques fail to completely differentiate into DCs in
response to human GM-CSF and IL-4 in culture. This is
likely given the low to moderate levels of DC-SIGN observed
on monocyte-derived DCs from rhesus and pig-tailed
macaques, respectively, in culture instead of the high level
of DC-SIGN expression typically found on the surface of
human monocyte-derived DCs (Geijtenbeek et al., 2000; Wu
et al., 2002a; Yu Kimata et al., 2002). Although we cannot
completely rule out that the T-cells are stimulating virus
production in macrophages or DCs, our data suggest that the
extent to which the SIVmne variants replicate in cocultures of
monocyte-derived macrophages or DCs and PBLs was most
likely due to the level of viral replication in CD4+T-cells.
Using a transwell culture system, we demonstrated that
contact between macrophages or DCs and T-cells is
necessary for efficient replication of SIVmne027. Moreover,
viral replication was enhanced by the interaction as it was
higher in macrophage- or DC–PHA-lymphoblast cocultures
than in infected PHA-lymphoblasts separated from either
the macrophages or DCs by the transwell membrane or
infected macrophages or DCs separated from uninfected
PHA-lymphoblasts by the membrane. These data agree with
previous studies on HIV-1 and indicate that cell-associated
presentation of SIV may be a more potent mechanism of
infection than cell-free virus infection (Gummuluru et al.,
2002; McDonald et al., 2003). Furthermore, the enhanced
replication of SIVmne027 in cocultures of macrophages or
DCs and resting T-cells further suggests that T-cell
activation resulting from intercellular interactions may
promote a permissive environment for viral replication.
Cytokines such as IL2, IL4, IL7, or IL15 render resting
CD4+T-cells susceptible for HIV-1 infection and replication
(Chun et al., 1998; Scripture-Adams et al., 2002; Smithgall
et al., 1996; Unutmaz et al., 1999). However, we found that
these cytokines did not support replication of SIVmne027 in
resting macaque T-cell cultures, whereas contact with either
macrophages or DCs could promote virus replication. It is
possible that the amount of p27gag produced from cytokine-
stimulated resting T-cells was below the minimum level of
detection; therefore, we cannot rule out that low level virus
expression occurs when infected resting T-cells are stimu-
lated with cytokines. Additional studies will be necessary to
determine whether there is a block to infection of cytokine-
stimulated resting macaque T-cells or if low copies of viral
transcripts and integrated proviral DNA are present.
Furthermore, it will be important to examine the ability of
resting T-cells to support SIV replication given that resting
T-cells in vivo are widely infected and produce low levels of
virus (Zhang et al., 1999).
The process of DC-enhanced HIV-1 and SIV infection
and replication in CD4+T-cells involves DC-SIGN (Geij-
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demonstrated that a single dose of an anti-ptDC-SIGN
monoclonal antibody could reduce capture of SIVmne027
by pig-tailed macaque DC (Yu Kimata et al., 2002). Here,
we demonstrate that continuous treatment with the antibody
almost completely inhibits viral replication. Surprisingly, we
also found that addition of the anti-ptDC-SIGN monoclonal
antibody after the initial transfer of virus from DC to T-cells
still inhibited virus replication by 90%. These data imply
that DC-SIGN may play a role in subsequent rounds of
replication as a capture and transfer factor. The data also
raise the possibility that DC-SIGN may also enhance viral
replication by stimulating target T-cells through ICAM-3,
thereby prolonging permissivity of CD4+T-cells for infec-
tion and replication. Although a previous study indicated
that ICAM-3 is not involved in DC-SIGN-mediated
enhancement of infection (Wu et al., 2002b), those experi-
ments were performed with cell lines, not primary cells.
Thus, whether DC-SIGN also promotes viral replication
through an ICAM-3-dependent T-cell activation mechanism
remains unknown.
DC-SIGN is unlikely to be involved in viral replication
in macrophage–T-cell cocultures. We had previously demon-
strated that ptDC-SIGN is not present on pig-tailed macaque
monocyte-derived macrophages (Yu Kimata et al., 2002).
Because the macrophages are infected by SIVmne027, it is
likely that virus produced from the macrophages is
efficiently transmitted to T-cells in context of other
costimulatory molecules as has been shown for SIVpbj, or
virus could be presented by syndecans, another capture
factor expressed on macrophages (Bobardt et al., 2003; Du
et al., 1995; Saphire et al., 2001). A recent study on HIV-1
infection of macrophages demonstrated that nef induces
expression of soluble CD23 and ICAM, which in turn
promote lymphocyte permissivity to HIV-1 infection (Swin-
gler et al., 2003). While we cannot rule out a role for these
molecules, our studies and those of Du et al. (1995) and
Kimata et al. (1998) indicate that macrophages must contact
T-cells to increase SIV infection and replication.
Early studies on HIV-1 and SIV demonstrated that nef
enhanced viral replication in the T-cell compartment when
transmitted by DCs (Messmer et al., 2000; Petit et al.,
2001). Nef has also been shown to increase SIV and HIV-1
replication in CD4+T-cells of lymph nodes in macaques and
in human lymph node tissue ex vivo, respectively (Glush-
akova et al., 1999; Sugimoto et al., 2003). Our data agree
with those studies. Furthermore, they indicate that mutations
in nef that are selected during infection of the host promote
viral replication in T-cells following transmission by either
macrophages or DCs. Increased viral infectivity and CD4
downregulation are characteristics of the SIVmne027 nef
allele compared to that of SIVmneCl8, indicating that these
activities may contribute to the increased replicative fitness
of this virus (Patel et al., 2002). Mutational analyses of HIV-
1 and SIVmac nef alleles have also linked these nef
activities with efficient viral replication (Glushakova et al.,2001; Iafrate et al., 2000; Stoddart et al., 2003). Additio-
nally, nef has also been shown to enhance T-cell activation
(Du et al., 1995; Schrager and Marsh, 1999; Wang et al.,
2000). Whether the SIVmne027 nef allele enhances T-cell
activation is unknown, but it will be important to determine
if this activity is also involved in increasing viral replication
in CD4+T-cells.
Optimal replication in APC–T-cell cocultures by
SIVmne027 also depended on a second determinant found
in pol that includes portions of the protease and reverse
transcriptase coding regions. These data corroborate with
our earlier studies demonstrating that this determinant
increases viral infectivity (Patel et al., 2002), although the
mechanism is not yet known. Whether the mutations are
unique to SIVmne027 or common among SIVmne variants
found in macaques with high viral loads is also unclear.
Therefore, it will be necessary to identify the exact mutation
involved in enhanced infectivity and determine its preva-
lence among variants that evolve during infection to
establish its importance for replication. Further in vivo
studies will also be required to confirm its importance for
replication in the host.
Competitive replication assays using HIV-1 isolates from
progressors and long-term survivors have suggested a link
between replicative fitness and viral load in vivo (Quinones-
Mateu et al., 2000). The advantage of the SIV macaque
model is that it provides an opportunity to experimentally
examine questions about fitness with molecularly defined
viruses. In this capacity, we have demonstrated that the
SIVmne027 variant replicates to higher levels in vivo and
causes a more rapid disease course compared to SIV-
mneCl8, indicating that replicative capacity in vitro may in
fact be a strong predictor of viral load, and consequently,
disease progression (Kimata et al., 1999b). Although
changes in the viral envelope contribute to fitness of
SIVmne in the host, our data show that mutations occurring
in nef and pol may also play a primary role in modulating
replicative capacity in the host. These changes may
contribute to the overall fitness of late-stage variants and
may account for differences in viral load and disease
progression.Materials and methods
Viruses
The molecular cloning and in vivo phenotypes of
SIVmneCl8 and SIVmne027 have been previously
described (Heidecker et al., 1998; Kimata et al., 1998;
Overbaugh et al., 1991). SIVmneCl8 is a minimally
pathogenic virus that is representative of variants found in
the early stages of infection with SIVmne. SIVmne027 was
cloned directly from lymph node tissue DNA of a macaque
infected with the SIVmne biological isolate from which
SIVmneCl8 was cloned. SIVmne027 shares similarities to
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capacity and pathogenicity in pig-tailed macaques relative to
SIVmneCl8 (Kimata et al., 1999b). The methods for
constructing the chimeric viruses 027/8, 8/027gag, 8/
027pol, and 8/027nef that contain different regions of
SIVmne027 in the background of the minimally pathogenic
clone SIVmneCl8 were described previously by Patel et al.
(2002). Regions of the envelope transmembrane intra-
cytoplasmic tail and LTR overlapping the nef coding
sequence are conserved between SIVmneCl8 and
SIVmne027, and therefore, are not expected to alter activity
of the chimeric viruses (Kimata et al., 1998). To construct
the 8/027pol-nef chimera, which contains the pol and nef
regions of SIVmne027 in the background of SIVmneCl8, a
BstBI–SphI fragment from 8/027pol was replaced with
homologous sequences from the 8/027nef mutant (Patel
et al., 2002).
To generate stocks of infectious virus, 293T cells were
transiently transfected with each proviral clone. Two
hundred fifty thousand cells were plated into wells of 6-
well plates and cultured in Dulbecco’s modified Eagles
medium (DMEM) supplemented with 10% heat-inactivated
fetal bovine serum, 2 mM l-glutamine, 100 U of penicillin
per ml, and 100 Ag of streptomycin per ml (DMEM
complete). The following day the cells were transfected by
the FuGene6 method (Roche, Indianapolis, IA) using 2 Ag
of each proviral clone. After 16-h incubation, the cells
were washed with phosphate-buffered saline (PBS), and
fresh DMEM complete was added to each culture. At 48 h
post-transfection, the supernatants were harvested, passed
through 0.2 Am-pore-size syringe filters (Corning Inc.,
Corning, NY), and stored at 80 8C. To determine the titer
of each virus stock, serial dilutions of supernatants were
tested for infections virus using the sMAGI assay
(Chackerian et al., 1995).
Macrophage, DC, and T-cell isolation and infection
All primary cells used were isolated from peripheral
blood samples obtained from SIV and simian retrovirus-
negative pig-tailed macaques at the Washington National
Primate Research Center, Seattle, WA. Macrophages were
derived from monocytes isolated by adherence to plastic as
previously described (Rudensey et al., 1995). Monocytes
were seeded into wells of 48-well trays at 2.5  105 cells
per well and then were differentiated in RPMI 1640
medium, 10% heat-inactivated fetal bovine serum, 2 mM
l-glutamine, 100 U of penicillin per ml, and 100 Ag of
streptomycin per ml (RPMI complete) supplemented with
10% GCT conditioned medium for 7 days before use in
experiments. At day 7, the monocyte-derived macrophages
were infected with either SIVmne027 or SIVmneCl8 at a
MOI of 0.01 to compare replication. Four hours post-
infection, cells were washed two times with PBS to remove
cell-free virus, and then cultured in fresh RPMI complete
with 10% GCT conditioned medium. Every 2–3 dayspostinfection, one-half of the supernatant was removed
from each culture and replaced with fresh RPMI complete
containing 10% GCT-conditioned medium. The superna-
tants were saved at 80 8C until analyzed for virion
production by SIV p27gag antigen enzyme-linked immuno-
sorbent assay (ELISA; Coulter-Immunotech, Miami, Fla.).
Pig-tailed macaque monocyte-derived DCs were gene-
rated as previously described (Yu Kimata et al., 2002).
CD14+monocytes were isolated from pig-tailed macaque
peripheral blood mononuclear cells (PBMCs) using anti-
CD14-microbeads and the miniMACS system according to
the manufacturer’s protocol (Miltenyi Biotec, Auburn,
CA). Recovered CD14+monocytes were cultured in RPMI
complete with 1000 U of granulocyte-macrophage colony-
stimulating factor (GM-CSF) per ml and 500 U of
interleukin-4 (IL-4) per ml (R&D Systems, Minneapolis,
MN) for 7 days to generate DCs. The cells expressed
moderately high levels of HLA-DR, moderate levels of
CD86 and DC-SIGN, and low levels of CD83 and CD25
when analyzed by fluorescence activated cell sorting
(FACS) as described (Yu Kimata et al., 2002). The
CD14 population of cells, which was primarily lympho-
cytes (PBLs), was frozen at 80 8C in RPMI complete
plus 10% DMSO until 3 days before cocultivation with
DCs, at which point they were thawed and stimulated with
10 Ag of phytohemagglutinin (PHA) per ml and IL-2
(50 U/ml) in RPMI complete medium (PHA-lymphoblasts)
and subsequently used for infection experiments. FACS
analysis demonstrated that the stimulated cells consisted
mainly of CD4+and CD8+T-cells.
To examine SIV infection and replication in DCs, the
monocyte-derived DCs were seeded at 1  105 cells per
100 Al of RPMI complete plus GM-CSF (1000 U/ml) and
IL-4 (500 U/ml) in wells of a 96-well plate and infected with
either SIVmneCl8 or SIVmne027 at a MOI 0.01. After 4 h,
cells were washed twice with PBS, resuspended in fresh
medium, and plated in wells of a 48-well dish. Over a 2-
week period, one-half of the supernatant was removed from
each well and replaced with fresh medium every 2–3 days.
Supernatants were saved at 80 8C until analyzed for SIV
p27gag antigen by ELISA.
To enrich for resting T-cells from pig-tailed macaque
PBMC, the CD14 cells that remained after isolation of
monocytes using Miltenyi anti-CD14 microbeads were
passed through T-cell enrichment columns (R&D systems)
that employ a negative selection method. By FACS analysis,
the cells recovered from the columns routinely consisted of
CD3+CD4+and CD3+CD8+T-cells and were negative for
CD20 or CD14. Less than 0.5% of the cells were positive
for CD25, CD69, or HLA-DR.
The antibodies used for FACS analysis (anti-HLA-DR
(G46-6), anti-CD14 (M5E2), anti-CD86, (FUN-1), anti-
CD83 (HB15e), anti-CD25 (M-A251), anti-CD69 (FN50),
anti-CD20 (2H7), anti-CD4 (L200), anti-CD8 (SK1), and
anti-CD3(SP34)) were obtained from BD Pharmingen
(San Diego, CA). The mouse anti-pig-tailed macaque
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generated and characterized previously (Yu Kimata et al.,
2002).
To examine infection and replication in resting T-cells,
2.5  105 cells were seeded into wells of U-bottom 96-well
trays and infected with 2500 tissue culture infectious doses
of either SIVmneCl8 or SIVmne027 in a total volume of
100 Al. Four hours postinfection, the cells were washed
twice with PBS and resuspended in RPMI complete
medium. At 2- to 3-day intervals, one-half the supernatants
were harvested from each well, saved at 80 8C, and later
tested for SIV p27gag by ELISA to monitor virus replication.
Fresh medium was added back to each culture.
Macrophage- and DC-lymphocyte cocultures
Macrophages (2  104) or DCs (1  104) were seeded
with autologous resting PBL or PHA-lymphoblasts (2 
105) and infected with SIVmneCl8 or SIVmne027 at a MOI
0.001. Supernatants were harvested every 2–3 days to
monitor virus replication by SIV p27gag antigen ELISA. To
assess the effect of cell contact on SIV replication, macro-
phages or DCs were incubated with virus for 3 h, washed,
and reseeded in fresh growth medium into the lower part of
transwell dishes (Corning). PHA-lymphoblasts were added
to the upper chamber of the transwell, which separates the
cells from the macrophages or DCs by a membrane with a
pore size of 0.4 Am. Culture supernatants were monitored
every 2–3 days for virion production by p27gag antigen
ELISA. Alternatively, PHA-lymphoblasts were first infected
and then cultured with uninfected macrophages or DCs with
or without separation by a transwell membrane.
DC-SIGN capture and transfer assay
To examine transfer of virus from DCs to T-cells, DCs
(1  104) were incubated with 1000 tissue culture infectious
doses (TCID) of SIVmne027 for 3 h at 37 8C in a 5% CO2
incubator. DCs were then washed twice with PBS and
resuspended in RPMI complete containing IL2 (50 U/ml),
IL4 (500 U/ml), and GM-CSF (1000 U/ml). The DCs were
then added to cultures of autologous PHA-lymphoblasts
(2  105). Cultures were maintained in RPMI complete
containing IL2, IL4, and GM-CSF. At 3- to 4-day intervals,
supernatants were harvested, saved at 70 8C, and later
tested for SIV p27gag antigen by ELISA to monitor virus
replication. All infections were performed in duplicate.
To examine DC-SIGN dependence of virus transmission
from DC to T-cells, duplicate cultures of DCs were first
incubated for 20 min at 37 8C with the mouse anti-ptDC-
SIGN monoclonal antibody 8C1 or control antibody at a
final concentration of 25 Ag/ml. Virus was then added to the
DC cultures. Cells were washed to remove unbound virus
and incubated with PHA-stimulated PBLs in the presence of
25 Ag/ml of 8C1 antibody. Alternatively, DC–T-cell cocul-
tures were infected with SIVmne027 24 h before addition of8C1. Supernatants were harvested every 3–4 days and
assayed for SIV p27gag to monitor virus replication.
Detection of SIV by PCR
DCs or macrophages were infected with SIVmne027. To
reduce the amount of viral DNA associated with virus-
containing supernatants used for infection, SIVmne027
stocks were treated with RNase-free DNAse (50 U/ml;
Roche) for 30 min at room temperature in the presence of
10 mM MgCl2. Cells were incubated with virus for 4 h at
37 8C, washed twice with RPMI complete medium, and
resuspended in RPMI complete plus 10% GCT conditioned
medium (for macrophages) or RPMI complete medium plus
GM-CSF and IL4 (DCs). Three days postinfection, cells
were collected, washed twice with PBS, and lysed in PCR
lysis buffer (50 mM KCl, 10 mM Tris–HCl [pH 8.3],
2.5 mM MgCl2, 0.1 mg of gelatin per ml, 0.45% Nonidet P-
40, and 0.45% Tween 20 plus 10 Ag of proteinase K per ml),
and incubated at 56 8C for 1 h. Lysates were used for
detection of late, LTR-UTR (R-untranslated region), inter-
mediates of reverse transcription by nested PCR, or
quantitative real-time taqman PCR.
For DNA amplification by nested PCR, the first round
of amplification was first carried out with the internal
primer pair SIV-LTR1/SIVUTR2 and second round of
amplification was done with the primer set SIV-LTR3/SIV
UTR4 as previously described by Chackerian et al.
(1997). This amplifies a 250-base pair (bp) product
between R and the untranslated region just 5V to the
Gag start codon (R-UTR). Serial dilutions of each lysate
were analyzed to quantify the amount of viral DNA. To
verify the amount of viral DNA, a primer set (forward
primer, U52-Taq: 5V-CTGTAAGGACCCTTTCTGCTTTG-
3V; reverse primer, GAG1-Taq: 5V-CACTCTCCTT-
CAAGTCCCTGTTC-3V) and oligonucleotide probe (5V-
CAGGAAAATCCCCTAGCAGATTGGCGC-3V) for real-
time taqman PCR were developed. These primers bound
viral DNA in the same vicinity as the nested PCR
primers. The oligonucleotide probe was modified with 6-
FAM (6-carboxyfluorescein) reporter dye on the 5V end
and 6-TAMRA (6-carboxytetramethylrhodamine) quencher
dye on the 3V end. Reactions were carried out in a 50-Al
volume using 200 nM each of the forward and reverse
primers and 200 nM of the fluorescent probe. The PCR
reactions were analyzed using an ABI prism 7700
sequence detection system. The PCR conditions were
2 min at 50 8C, 10 min at 95 8C, followed by 40 cycles
of 15 s at 95 8C, and 1 min at 62 8C. A standard curve
for viral DNA was prepared using serial dilutions of a
SIVmne027 R-UTR DNA sequence diluted in a constant
amount of sheared salmon sperm DNA. To correct for
variation in cell numbers, the amount of h-actin DNA was
also measured and compared against serial dilutions of
cellular DNA isolated from pig-tailed macaque peripheral
blood mononuclear cells.
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